Find Articles



Return to:Adhd Articles
Or:Recent Adhd Articles

Prolonged Release Of Mesalamine In An In Vitro Study Using A Simulated ...


http://www.medicalnewstoday.com/articles/85966.php

Medical News Today - Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the ...



Article Finder:

October 18, 2007 05:54:00 AM
Article Directory